Recombinant SIGLEC8 (Lirentelimab Biosimilar) antibody

Catalog No. ABIN7675687

The Human Monoclonal anti-SIGLEC8 (Lirentelimab Biosimilar) antibody (ABIN7675687) specifically detects SIGLEC8 (Lirentelimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. The antibody is reactive with Human samples.

Quick Overview for Recombinant SIGLEC8 (Lirentelimab Biosimilar) antibody (ABIN7675687)

Target: SIGLEC8 (Lirentelimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This SIGLEC8 (Lirentelimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-SIGLEC8 (Lirentelimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-Siglec-8 Reference Antibody (lirentelimab)

Characteristics: Anti-Siglec-8 Reference Antibody (lirentelimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 143.56 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for SIGLEC8 (Lirentelimab Biosimilar)

Target: SIGLEC8 (Lirentelimab Biosimilar)

Alternative Name: Siglec-8 (Lirentelimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 143.56 kDa

UniProt: Q9NYZ4